HomeCAPR • NASDAQ
add
Capricor Therapeutics Inc
Previous close
$9.56
Day range
$9.07 - $9.94
Year range
$3.52 - $23.40
Market cap
431.48M USD
Avg Volume
2.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 6.07M | 49.01% |
Net income | -24.39M | -149.04% |
Net profit margin | — | — |
Earnings per share | -0.53 | -70.97% |
EBITDA | -24.63M | -147.89% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 151.52M | 279.58% |
Total assets | — | — |
Total liabilities | — | — |
Total equity | 145.46M | — |
Shares outstanding | 45.68M | — |
Price to book | 3.00 | — |
Return on assets | — | — |
Return on capital | -42.51% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -24.39M | -149.04% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
2005
Website
Employees
160
